Sensitisation of Ehrlich ascitic tumour cells to methotrexate by inhibiting glutaminase

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3315-3320

  Alonso, Francisco J ^a   Segura, Juan A ^a   Lora, Jorge ^a   Lobo, Carolina ^a   Fernández Molina, Beatriz ^a   Márquez, Javier ^a   Matés, José M ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Apoptosis; Cancer; Chemoresistance; Glutaminase; Glutamine

Indexed keywords

GLUTAMINASE; HYDROGEN PEROXIDE; MESSENGER RNA; METHOTREXATE; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL VIABILITY; DRUG CYTOTOXICITY; DRUG EFFECT; EHRLICH ASCITES TUMOR; ENZYME INHIBITION; FLOW CYTOMETRY; PRIORITY JOURNAL; TUMOR CELL CULTURE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CARCINOMA, EHRLICH TUMOR; CELL GROWTH PROCESSES; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GLUTAMINASE; HYDROGEN PEROXIDE; METHOTREXATE; RNA, ANTISENSE; RNA, MESSENGER;

EID: 23344450821     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Aledo JC, de Pedro E, Gómez-Fabre PM, Nuñez de Castro I and Márquez J: Changes in mRNAs for enzymes of glutamine metabolism in the tumor-bearing mouse. Anticancer Res 30: 1463-1466, 2000.
2. Lobo C, Ruíz-Bellido MA, Aledo JC, Márquez J, Nuñez de Castro I and Alonso FJ: Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem J 348: 257-261, 2000.
3. Lora J, Alonso FJ, Segura JA, Lobo C, Márquez J and Matés JM: Antisense glutaminase inhibition decreases glutathione antioxidant capacity and increases apoptosis in Ehrlich ascitic tumour cells. Eur J Biochem 271: 4298-4306, 2004.
4. Ahmad S, White C, Chang L, Scheneider B and Allen C: Glutamine protects mitochondrial structure and function in oxygen toxicity. Am J Physiol Lung Cell Mol Physiol 280: L779-791, 2001.
5. Oehler R and Roth E: Regulative capacity of glutamine. Curr Opin Clin Nutrit Metabol Care 6: 277-282, 2003.
6. Chang WK, Yang KD, Chuang H, Jan JT and Shaio MF: Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels. Clin Immunol 104: 151-160, 2002.
7. Gu Y, Wu Z, Xie J, Jin D and Zhuo H: Effects of growth hormone (rhGH) and glutamine supplemented parenteral nutrition on intestinal adaptation in short bowel rats. Clin Nutr 20: 159-166, 2001.
8. Wu G, Fang Y, Yang S, Lupton J and Turner N: Glutathione metabolism and its implications for health. J Nutr 134: 489-492, 2004.
9. Obrador E, Carretero J, Esteve JM, Pellicer JA, Pascual A, Petschen I and Estrela JM: Glutamine potentiates TNF-alpha-induced tumor cytotoxicity. Free Rad Biol Med 31: 642-650, 2001.
10. Todorova VK, Harms SA, Kaufmann Y, Luo S, Luo KQ, Babb K and Klimberg VS: Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of rats. Breast Cancer Res Treat 88: 247-256, 2004.
11. Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL and Finlay JL: Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 22: 4881-4887, 2004.
12. van Engeland M, Nieland L, Ramaekers F, Schutte B and Reutelingsperger C: Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31: 1-9, 1998.
13. Janossy G, Jani IV, Kahan M, Barnett D, Mandy F and Shapiro H: Precise CD4 T-cell counting using red diode laser excitation: for richer, for poorer. Cytometry 50: 78-85, 2002.
14. Biroccio A, D'Angelo C, Jansen B, Gleave ME and Zupi G: Antisense clusterin oligodeoxynucleotides increase the response of HER-2 gene amplified breast cancer cells to Trastuzumab. J Cell Physiol 4(204): 463-469, 2005.
15. Zhao ZG and Shen WL: Heat shock protein 70 antisense oligonucleotide inhibits cell growth and induces apoptosis in human gastric cancer cell line SGC-7901. World J Gastroenterol 11: 73-78, 2005.
16. Amantana A, London CA, Iversen PL and Devi GR: X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 3: 699-707, 2004.
17. Segura JA, Ruíz-Bellido MA, Arenas M, Lobo C, Márquez J and Alonso FJ: Ehrlich ascites tumor cells expressing anti-sense glutaminase mRNA lose their capacity to evade the mouse immune system. Int J Cancer 91: 379-384, 2001.
18. Yin L, Huang L and Kufe D: MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress. J Biol Chem 279: 45721-45727, 2004.
19. Fleury C, Mignotte B and Vayssiere JL: Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84: 131-141, 2002.
20. Schmitz I, Kirchhoff S and Krammer PH: Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol 32: 1123-1136, 2000.
21. Lytle RA, Jiang Z, Zheng X and Rich KM: BCNU down-regulates anti-apoptotic proteins bcl-xL and Bcl-2 in association with cell death in oligodendroglioma-derived cells. J Neurooncol 68: 233-241, 2004.
22. Ozvaran MK, Cao XX, Miller SD, Monia BA, Hong WK and Smythe WR: Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma. Mol Cancer Ther 3: 545-550, 2004.
23. Hayward RL, Macpherson JS, Cummings J, Monia BP, Smyth JF and Jodrell DI: Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: genetic evidence for specificity of the antisense effect. Mol Cancer Ther 3: 169-178, 2004.
24. Klimberg VS, Nwokedi E, Hutchins LF, Pappas AA, Lang NP, Broadwater JR, Read RC and Westbrook KC: Glutamine facilitates chemotherapy while reducing toxicity. J Parenter Enteral Nutr 16: 83S-87S, 1992.
25. Klimberg VS, Pappas AA, Nwokedi E, Jensen JC, Broadwater JR, Lang NP and Westbrook KC: Effect of supplemental dietary glutamine on methotrexate concentrations in tumors. Arch Surg 127: 1317-1320, 1992.
26. Peñuelas S, Noé V, Morales R and Ciudad CJ: Sensitization of human erythroleukemia K562 cells resistant to methotrexate by inhibiting IMPDH. Med Sci Monit 11: BR6-BR12, 2005.
27. Dai DJ, Lu CD, Lai RY, Guo JM, Meng H, Chen WS and Gu J: Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells. World J Gastroenterol 11: 193-199, 2005.
28. Fu XH, Zhang JS, Zhang N and Zhang YD: Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line. World J Gastroenterol 11: 785-790, 2005.
29. Anderson PM, Schroeder G and Skubitz KM: Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 83: 1433-1439, 1998.